Patent details

Basic Information

Publication number:

EP3024442

PCT Application Number:

EP2014065661

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147418768

PCT Publication Number:

WO2015011113

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS CONTAINING AMORPHOUS DAPAGLIFLOZIN

French Title of Invention:

COMPOSITIONS COMPRENANT DAPAGLIFLOZIN AMORPHE

German Title of Invention:

ZUSAMMENSETZUNGEN MIT AMORPHEM DAPAGLIFLOZIN

SPC Number:

Dates

Filing date:

22/07/2014

Grant date:

16/01/2019

EP Publication Date:

01/06/2016

PCT Publication Date:

29/01/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/01/2019

EP B1 Publication Date:

16/01/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/07/2019

Expiration date:

22/07/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/01/2019

 

 

Name:

Sandoz AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

GRAHEK, Rok

Address:

Slovenia (SI)

2

Name:

STANIC LJUBIN, Tijana

Address:

Slovenia (SI)

3

Name:

PETERNEL, Luka

Address:

Slovenia (SI)

4

Name:

BERGLEZ, Sandra

Address:

Slovenia (SI)

5

Name:

STARIC, Rok

Address:

Slovenia (SI)

6

Name:

GRMAS, Jernej

Address:

Slovenia (SI)

Priority

Priority Number:

13177508

Priority Date:

22/07/2013

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/16; A61K 9/20; A61K 31/70;

Publication

European Patent Bulletin

Issue number:

201903

Publication date:

16/01/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages